Tag: Prescription Drugs
Anticoagulation Report Has Little Impact in Discharge Summary
Safe Transitions Anticoagulation Report has no impact on clinical outcomes for patients on warfarin
For Pharma Reps, Access to Physicians Continuing to Drop
Only 47 percent of prescribers considered accessible in 2015, compared with 55 percent in 2013
Vemurafenib Deemed Highly Effective in Hairy-Cell Leukemia
Findings from two phase 2 studies in Italy and United States show short oral course is highly effective
Supportive Evidence for Daily PrEP Curbing HIV Transmission
This preventive treatment should be routinely offered to gay men at high risk, researchers say
CDC: ER Visits for Medication Overdoses in Children Down
Four meds caused 91.2 percent of visits for over-the-counter liquid medication exposures
ICER: New Cholesterol Drugs Highly Overpriced
Newly FDA-approved Repatha and Praluent currently cost more than $14,000 per year
Imetelstat Deemed Active in Myelofibrosis, Thrombocythemia
Responses for patients with myelofibrosis, essential thrombocythemia
Daily PrEP Prevents HIV Infection in High-Risk Individuals
Study participants were infected with other sexually transmitted diseases
Finerenone Linked to Improved UACR in Diabetic Nephropathy
Addition of finerenone to ACE inhibitor or ARB tied to reduction in urinary albumin-creatinine ratio
Study Compares Hospitalized Infection Risk for Biologics in RA
Risk of hospitalized infection increased with etanercept, infliximab, rituximab versus abatacept
